Septo-Optic Dysplasia

Neurology·MeSH: Septo-Optic Dysplasia

Prevalence

30.0 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Septo-Optic Dysplasia?

There are 1 clinical trial targeting Septo-Optic Dysplasia tracked by BioSniper.

What is the prevalence of Septo-Optic Dysplasia?

The estimated prevalence of Septo-Optic Dysplasia is approximately 30.0 per 100,000 population.

Deep-dive into Septo-Optic Dysplasia

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Septo-Optic Dysplasia — Drugs in Development & Clinical Trials | BioSniper